Mon, 08/05/2024 - 11:27 |
Mallinckrodt Reaches Agreement to Sell Therakos Business to CVC for $925 Million |
Mallinckrodt |
Sun, 07/28/2024 - 11:53 |
Attorney General James Secures $86 Million Multistate Settlement in Principle with Indivior for Its Role in the Opioid Crisis |
New York Attorn... |
Thu, 05/30/2024 - 18:20 |
Attorney General James Appoints New York City Public Health Advocate Tracie M. Gardner to Opioids Settlement Board |
New York Attorn... |
Thu, 05/09/2024 - 15:48 |
In re Mallinckrodt UpdateThird Circuit Agrees with Lower Courts: Royalty Obligations Not Tied to IP License Are Dischargeable Unsecured Claims |
Covington |
Mon, 03/04/2024 - 19:35 |
Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands |
Mallinckrodt |
Thu, 02/01/2024 - 18:57 |
Attorney General James Secures $150 Million Multistate Settlement in Principle with Hikma Pharmaceuticals to Help Combat Opioid Crisis |
New York Attorn... |
Wed, 09/28/2022 - 12:04 |
Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System |
Mallinckrodt |
Thu, 06/16/2022 - 17:00 |
Attorney General James Secures $58.5 Million from Top Opioid Manufacturer Mallinckrodt for Fueling Opioid Crisis |
New York Attorn... |
Wed, 03/23/2022 - 12:07 |
Silence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501 |
Mallinckrodt |
Wed, 03/02/2022 - 12:34 |
Attorney General James Recovers $26.8 Million from Drug Manufacturer Mallinckrodt for Medicaid Fraud |
New York Attorn... |
Mon, 12/20/2021 - 12:32 |
Gov. Evers, state leaders tour UW biotech spinoff Stratatech |
University of W... |
Fri, 09/03/2021 - 02:48 |
Mallinckrodt Reaches Settlements with the Official Committee of Opioid Related Creditors, the Official Committee of Unsecured Creditors and Second Lien Noteholders |
Mallinckrodt |
Thu, 08/05/2021 - 19:14 |
Paxton Joins $21 Billion Opioid Distributor Settlement |
Texas Attorney ... |
Thu, 07/08/2021 - 14:31 |
Attorney General James Helps Shut Down Purdue Pharma, Secures $4.5 Billion from Sackler Family for Role in Fueling Opioid Crisis |
New York Attorn... |
Wed, 06/30/2021 - 06:17 |
Attorney General James Applauds Signing of Bill Creating Opioid Settlement Fund Into Law |
New York Attorn... |
Tue, 06/29/2021 - 03:15 |
Attorney General James Statement at Commencement of Trial Against Various Opioid Manufacturers and Distributors |
New York Attorn... |
Mon, 03/29/2021 - 16:40 |
National Association of Manufacturers Selects Mallinckrodt for Two Prestigious Manufacturing Leadership Awards |
Mallinckrodt |
Wed, 03/24/2021 - 06:13 |
Mallinckrodt Supports Healthcare Businesswomens Association as Two Employees Honored with Prominent Awards |
Mallinckrodt |
Fri, 03/19/2021 - 06:08 |
Mallinckrodt Announces 2021 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award |
Mallinckrodt |
Wed, 03/10/2021 - 16:59 |
Mallinckrodt Gains Support for Its Restructuring Support Agreement from Lenders Holding Approximately $1.3 Billion of Its First Lien Term Loans |
Mallinckrodt |
Fri, 02/12/2021 - 14:26 |
Mallinckrodt Provides Regulatory Update on StrataGraft |
Mallinckrodt |
Thu, 02/04/2021 - 08:25 |
Attorney General James Delivers More Than $573 Million to Communities Across the Nation to Fight Opioid Crisis |
New York Attorn... |
Fri, 01/29/2021 - 15:15 |
Mallinckrodt Earns Top Marks in Human Rights Campaigns 2021 Corporate Equality Index |
Mallinckrodt |
Mon, 01/04/2021 - 05:48 |
Endo Launches Authorized Generic Version of Amitiza (lubiprostone) Capsules in the United States |
Endo |
Mon, 11/16/2020 - 17:16 |
Mallinckrodt Announces Real World Data on Hepatorenal Syndrome (HRS) and Acute Kidney Injury (AKI) in Patients with Liver Disease at The Liver Meeting Digital Experience |
Mallinckrodt |